3 ms·
Precisely! Same thing as currently with access to vaccination and vitamin D.
by throwuxiytayq 4y ago
Precisely! Same thing as currently with access to vaccination and vitamin D.
- faluzure 4y agoPhhhhtttt, next you'll tell me the $25K 4k TV I bought in 2012 can be bought by the masses for next to nothing.
- ceejayoz 4y agoThat's great if the item/service in question can be mass produced. How much has the cost of a heart transplant gone down since its invention in 1967?
- spaced-out 4y agoDepends on what country you're looking at.
- jjk166 4y agoWhich a cure for aging would be.
- ceejayoz 4y agoHow would we know that before it exists?
- jjk166 4y agoBecause for it to qualify as a cure it must be mass producible. If it only works on one person, you haven't cured aging, you've merely repaired a body. Realistically though, we have a pretty good idea of what we're looking for. We don't know the exact combination of chemicals that cures aging, but we know it's going to be a combination of chemicals, and we know we can mass produce those.
- ceejayoz 4y agoIt'd be great if something as simple in mechanism and production as vaccination and vitamin D turned out to be the key to longevity. I tend to doubt it, though. I get a med that's $18k every three months, for a mililiter of fluid. I wouldn't have a hope of paying for that without health insurance, and I'd expect health insurers to be resistant to covering mega-expensive life extension therapies.
- inglor_cz 4y agoIs your disease uncommon? Generally, the more common diseases are cheaper to treat, because the burden of development, IP etc. gets spread across more people. Medications for ubiquitous stuff such as high blood pressure tend to be comparably cheap, unless they are a fresh novelty. And aging is even more widespread than HBP.
- ceejayoz 4y ago> Is your disease uncommon? Estimated at 2-3% of the world population, so 100M+ people.
- inglor_cz 4y agoSo is the treatment something highly unusual? I am sorry to be prying such information out of you, but things with such a cost label tend to be very high-tech (e.g. tumor-invading lymphocytes etc. that need to be cultivated for each patient separately, which cannot possibly be cheap).
- ceejayoz 4y agoIt's a monoclonal antibody. I suspect it'll look cheap in comparison to life extension treatments.
- jjk166 4y agoThat's because monoclonal antibodies are targeted to a very specific protein. Polyclonal antibodies which can be used more generally are much cheaper. You're paying for the purity, not the substance.